Relationship of serum osteocalcin levels with blood glucose, insulin resistance and lipid profile in central Indian men with type 2 diabetes

Archives of Physiology and Biochemistry

Volumn 118, Issue 5, 2012, Pages 260-264

  Sarkar, Purnima Dey ^a   Choudhury, Anil Baran ^b  

^a MGM Medical College   (India)

^b NSCB MEDICAL COLLEGE   (India)

Author keywords

Glucose homeostasis; HDL cholesterol; HOMA IR; Osteocalcin; Triglycerides

Indexed keywords

OSTEOCALCIN;

ARTICLE; BLOOD; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HUMAN; INDIA; INSULIN RESISTANCE; LIPID METABOLISM; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; HUMANS; INDIA; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MIDDLE AGED; OSTEOCALCIN;

EID: 84869391413     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2012.715651     Document Type: Article

References (41)

1. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H. (2004). PPARgamma insufciency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113:846-55.
2. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA, McQueen M. (2000). Diferences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic Groups (SHARE). Lancet 356:279-84.
3. Bennett JH, Joyner CJ, Triftt JT, Owen ME. (1991). Adipocytic cells cultured from marrow have osteogenic potential. J Cell Sci 99:131-9.
4. Beresford JN. (1989). Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop Relat Res 240:270-80.
5. Chan MH, Mak TW, Chiu RW, Chow CC, Chan IH, Lam CW. (2001). Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolaemia. J Clin Endocrinol Metab 86:4556-9.
6. Diascro DD Jr, Vogel RL, Johnson TE, Witherup KM, Pitzenber ger SM, Rutledge SJ, Prescott DJ, Rodan GA, Schmidt A. (1998). High fatty acid content in rabbit serum is responsible for the diferentiation of osteoblasts into adipocyte-like cells. J Bone Miner Res 13:96-106.
7. Epstein S. (1988). Serum and urinary markers of bone remodeling: assessment of bone turnover. Endocr Rev 9:437-49.
8. Fernández-Real JM, Izquierdo M, Ortega F, Gorostiaga E, Gómez-Ambrosi J, Moreno-Navarrete JM, Frühbeck G, Martínez C, Idoate F, Salvador J, Forga L, Ricart W, Ibañez J. (2009). Te relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 94:237-45.
9. Ferron M, Hinoi E, Karsenty G, Ducy P. (2008). Osteocalcin diferentially regulates beta cell and adipocyte gene expression and afects the development of metabolic diseases in wild type mice. Proc Natl Acad Sci USA 105:5266-70.
10. Friedewald W T, Levy RI, Fredrickson DS. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502.
11. Gundberg CM, Looker AC, Nieman SD, Calvo MS. (2002). Pattern of osteocalcin and bone specifc alkaline phosphatase by age, gender and race or ethnicity. Bone 31:703-8.
12. Gundberg CM, Nieman SD, Abrams S, Rosen H. (1998). Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab 83:3258-66.
13. Hamada Y, Fujii H, Fukagawa M. (2009). Role of oxidation stress in diabetic bone disorder. Bone 45:S35-8.
14. Hauschka PV, Lian JB, Cole DE, Gundberg CM. (1989). Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69:990-1047.
15. Hwang YC, Jeong IK, Ahn KJ, Chung HY. (2012). Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporo Int 23:1337-42.
16. Jackson SM, Demer LL. (2000). Peroxisome proliferator-activated receptor activators modulate the osteoblastic maturation of MC3T3-E1 preosteoblasts. FEBS Lett 471:119-24.
17. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. (1972). Indices of relative weight and obesity. J Chronic Dis 25:329-43.
18. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. (1994). Increasing prevalence of overweight among US adults. JAMA 272:205-11.
19. Lecka-Czernik B, Gubrij I, Moerman EJ, Kajkenova O, Lipschitz DA, Manolagas SC, Jilka RL. (1999). Inhibition of Osf2/Cbfa1 expression and terminal osteoblast diferentiation by PPARgamma2. J Cell Biochem 74:357-71.
20. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G. (2007). Endocrine regulation of energy metabolism by the skeleton. Cell 130:456-69.
21. Lee YJ, Lee H, Jee SH, Lee SS, Kim SR, Kim SM, Lee MW, Lee CB, Oh S. (2010). Serum osteocalcin is inversely associated with adipocyte-specifc fatty acid-binding protein in the Korean metabolic syndrome research initiatives. Diabetes Care 33:e90.
22. Lee SW, Jo HH, Kim MR, You YO, Kim JH. (2012). Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women. Gynecol Endocrinol 28:472-7.
23. Lim DW, Siti Aizon AH, Mohd Faris MF, Premalatha S, Nabila Farina R, Norlaila M, Khalidah MB. (2011). Osteocalcin is related to hyperglycaemia and insulin resistance but not lipids in metabolic syndrome patients. Med & Health 6:191.
24. Lin PH, Ginty F, Appel LJ, Aickin M, Bohannon A, Garnero P, Barclay D, Svetkey LP. (2003). Te DASH diet and sodium reduction improve markers of bone turnover and calcium metabolism in adults. J Nutr 133:3130-6.
25. Majima T, Shimatsu A, Komatsu Y, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. (2008). Increased bone turnover in patients with hypercholesterolemia. Endocr J 55:143-151.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-9.
27. McCabe LR. (2007). Understanding the pathology and mechanisms of type 1 diabetic bone loss. J Cell Biochem 102:1343-57.
28. Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, Territo M, Demer LL. (1999). Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic diferentiation of marrow stromal cells. J Bone Miner Res 14:2067-78.
29. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL. (1997). Lipid oxidation products have opposite efects on calcifying vascular cell and bone cell diferentiation. A possible explanation for the paradox of arterial calcifcation in osteoporotic patients. Arterioscler Tromb Vasc Biol 17:680-7.
30. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. (2009). Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 94:827-32.
31. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-7.
32. Price PA. (1989). Gla-containing proteins of bone. Connect Tissue Res 21:51-7.
33. Ramachandran A, Mary S, Yamuna A, Murugesan N, Snehalatha C. (2008). High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care 31:893-8.
34. Ruiz-Gaspa S, Nogues X, Enjuanes A, Monllau JC, Blanch J, Carreras R, Mellibovsky L, Grinberg D, Balcells S, Díez-Perez A, Pedro-Botet J. (2007). Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures. J Cell Biochem 101:1430-38.
35. Saleem U, Mosley TH Jr, Kullo IJ. (2010). Serum osteocalcin is associated with measure of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Tromb Vasc Biol 30:1474-78.
36. Tan A, Gao Y, Yang X, Zhang H, Qin X, Mo L, Peng T, Xia N, Mo Z. (2011). Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey. Metabolism 60:1186-92.
37. Verhaeghe J, Van Herck E, Visser WJ, Suiker AM, Tomasset M, Einhorn TA, Faierman E, Bouillon R. (1990). Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes 39:477-82.
38. Wang W, Zhang X, Zheng J, Yang J. (2010). High glucose stimulates adipogenic and inhibits osteogenic diferentiation in MG-63 cells through cAMP/protein kinase A/extracellular signal-regulated kinase pathway. Mol Cell Biochem 338:115-22.
39. World Health Organization. (1999). Defnition, diagnosis and classifcation of diabetes mellitus and its complications: report of a WHO consultation. Part 1: Diagnosis and Classifcation of Diabetes Mellitus. Geneva: World Health Organization.
40. Yeap BB, Chubb SA, Flicker L, McCaul KA, Ebeling PR, Beilby JP, Norman PE. (2010). Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur J Endocrinol 163:265-72.
41. Zhou M, Ma X, Li H, Pan X, Tang J, Gao Y, Hou X, Lu H, Bao Y, Jia W. (2009). Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol 161:723-9.